Sarepta Therapeutics (SRPT) News Today → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free SRPT Stock Alerts $127.39 +3.14 (+2.53%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSarepta Therapeutics, Inc. (NASDAQ:SRPT) Shares Sold by Sigma Planning Corpmarketbeat.com - April 26 at 6:40 AMEquities Analysts Set Expectations for Sarepta Therapeutics, Inc.'s FY2026 Earnings (NASDAQ:SRPT)americanbankingnews.com - April 26 at 3:34 AMSarepta Therapeutics, Inc. (NASDAQ:SRPT) Given Average Recommendation of "Moderate Buy" by Brokeragesamericanbankingnews.com - April 26 at 1:26 AMSemanteon Capital Management LP Purchases New Shares in Sarepta Therapeutics, Inc. (NASDAQ:SRPT)marketbeat.com - April 25 at 10:35 PMSarepta Therapeutics (SRPT) Scheduled to Post Earnings on Wednesdaymarketbeat.com - April 25 at 12:06 PMBullish Sarepta Therapeutics Insiders Loaded Up On US$13.3m Of Stockfinance.yahoo.com - April 25 at 11:47 AMZacks Research Equities Analysts Decrease Earnings Estimates for Sarepta Therapeutics, Inc. (NASDAQ:SRPT)marketbeat.com - April 25 at 9:12 AMQ1 2026 EPS Estimates for Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Lowered by Analystamericanbankingnews.com - April 25 at 2:36 AMSarepta Therapeutics (NASDAQ:SRPT) Shares Up 5.9%marketbeat.com - April 24 at 7:14 PMSarepta Therapeutics to Announce First Quarter 2024 Financial Resultsbusinesswire.com - April 24 at 8:30 AMQ1 2026 EPS Estimates for Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Cut by Analystmarketbeat.com - April 24 at 6:49 AMInternational Assets Investment Management LLC Boosts Holdings in Sarepta Therapeutics, Inc. (NASDAQ:SRPT)marketbeat.com - April 23 at 4:16 AMDuality Advisers LP Invests $2.78 Million in Sarepta Therapeutics, Inc. (NASDAQ:SRPT)marketbeat.com - April 22 at 11:54 AMWilliam Blair Analysts Decrease Earnings Estimates for Sarepta Therapeutics, Inc. (NASDAQ:SRPT)americanbankingnews.com - April 20 at 2:42 AMAnalysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Sarepta Therapeutics (SRPT) and Intuitive Surgical (ISRG)markets.businessinsider.com - April 19 at 12:34 PMFY2024 EPS Estimates for Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Decreased by Analystmarketbeat.com - April 19 at 8:50 AMFederated Hermes Inc. Has $68.31 Million Stock Position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT)marketbeat.com - April 19 at 8:45 AMMirae Asset Global Investments Co. Ltd. Sells 52,815 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)marketbeat.com - April 16 at 5:04 AM6,137 Shares in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Purchased by WCM Investment Management LLCmarketbeat.com - April 15 at 7:31 AMRSI Alert: Sarepta Therapeutics (SRPT) Now Oversoldnasdaq.com - April 15 at 12:19 AMAllspring Global Investments Holdings LLC Sells 80,841 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)marketbeat.com - April 14 at 5:37 AM10 Unstoppable Stocks That Will Make You Richerfinance.yahoo.com - April 13 at 10:21 PMSapient Capital LLC Takes $978,000 Position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT)marketbeat.com - April 13 at 7:45 AMPfizer: The Market Is Wrongseekingalpha.com - April 11 at 5:17 PMSarepta Therapeutics: Growth Trajectory Alters Trading Strategyseekingalpha.com - April 11 at 7:16 AMSarepta Therapeutics: A Buy Recommendation Amidst Undervaluation and Growth Potential for Elevidysmarkets.businessinsider.com - April 10 at 9:35 AMSarepta Therapeutics: Another 'Hold' Call Ahead Of Some Key Catalystsseekingalpha.com - April 8 at 4:11 PMWhy Sarepta's First-Quarter Report Is Already Dead In The Water: Analystfinance.yahoo.com - April 8 at 3:22 PMRBC sees Sarepta's Elevidys remaining on market: reportmsn.com - April 7 at 6:17 PM2 Biotech Stocks to Buy Hand Over Fist in Aprilfool.com - April 6 at 8:45 AMChina Universal Asset Management Co. Ltd. Purchases 8,427 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)marketbeat.com - April 5 at 10:20 AMBuy Rating on Sarepta Therapeutics Amidst Anticipated Drug Approval and Market Potentialmarkets.businessinsider.com - April 5 at 4:06 AMSarepta Therapeutics, Inc. (NASDAQ:SRPT) Receives Consensus Recommendation of "Moderate Buy" from Analystsmarketbeat.com - April 1 at 2:16 AMSarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)businesswire.com - March 29 at 4:00 PMSarepta Therapeutics, Inc. (NASDAQ:SRPT) Shares Sold by Assenagon Asset Management S.A.marketbeat.com - March 26 at 2:59 PMTrial results for Dravet drug spurs stock surge at Bedford biotechbizjournals.com - March 26 at 11:44 AMA Comprehensive Look at Sarepta's Growth and Innovationfinance.yahoo.com - March 25 at 7:14 PMSarepta Therapeutics, Inc. (NASDAQ:SRPT) Shares Acquired by Vanguard Group Inc.marketbeat.com - March 20 at 4:56 AMSRPT Jun 2024 80.000 callca.finance.yahoo.com - March 19 at 7:07 PMSarepta Therapeutics, Inc. (NASDAQ:SRPT) Director Stephen Mayo Sells 3,135 Sharesinsidertrades.com - March 16 at 9:12 AMWellington Management Group LLP Purchases 54,698 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)marketbeat.com - March 14 at 6:47 AMBuy Rating for Sarepta Therapeutics Amidst Promising Developments and Strategic Partnershipsmarkets.businessinsider.com - March 13 at 2:09 PMDoes This 1 New Threat Make Sarepta Therapeutics Stock Worth Selling?fool.com - March 13 at 8:00 AMDirector Wigzell Hans Lennart Rudolf Sells 15,000 Shares of Sarepta Therapeutics Inc (SRPT)finance.yahoo.com - March 12 at 7:51 AMSarepta Therapeutics, Inc. (NASDAQ:SRPT) Director Kathryn Jean Boor Sells 761 Sharesinsidertrades.com - March 12 at 6:10 AMHans Lennart Rudolf Wigzell Sells 15,000 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Stockinsidertrades.com - March 12 at 4:38 AMJacobs Levy Equity Management Inc. Has $48.18 Million Holdings in Sarepta Therapeutics, Inc. (NASDAQ:SRPT)marketbeat.com - March 10 at 11:00 AMEnvestnet Asset Management Inc. Buys 21,514 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)marketbeat.com - March 9 at 4:13 AMSRPT Mar 2024 80.000 putuk.finance.yahoo.com - March 9 at 1:38 AMGot $1,000? Buy These Hot Growth Stocks Before They Take Off.fool.com - March 8 at 5:45 AM Get Sarepta Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRPT and its competitors with MarketBeat's FREE daily newsletter. Email Address These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy SRPT Media Mentions By Week SRPT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SRPT News Sentiment▼0.260.37▲Average Medical News Sentiment SRPT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SRPT Articles This Week▼219▲SRPT Articles Average Week Get Sarepta Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: United Therapeutics News Today Catalent News Today Dr. Reddy's Laboratories News Today Karuna Therapeutics News Today BeiGene News Today Legend Biotech News Today Viatris News Today Ascendis Pharma A/S News Today Intra-Cellular Therapies News Today Cerevel Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SRPT) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sarepta Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
